← Back to Search

Supportive Care for Arthritis (RAISE Trial)

N/A

Waitlist Available

Led By Candace H Feldman, MD, MPH, ScD

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up -12 months through +12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial tests whether providing tailored lists of resources and/or a specialized nurse navigator to patients with inflammatory arthritis and SDoH-related needs can reduce missed appointments and improve health outcomes.

Who is the study for?

This trial is for adults over 18 with arthritis-related rheumatic conditions who missed at least one clinic visit in the past year and have social needs, except unemployment or education. They must be getting care at specific hospitals, speak English or Spanish, and not be enrolled in certain other care programs.

What is being tested?

The study tests three support strategies for patients with systemic rheumatic conditions: a tailored resource list (Arm 1), help from a community specialist (Arm 2), and assistance from a nurse navigator trained in these conditions working with the community specialist (Arm 3).

What are the potential side effects?

Since this trial involves non-medical interventions like providing resources and personal guidance rather than drugs or medical procedures, traditional side effects are not expected. However, there may be indirect effects on patients' well-being based on their experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ -12 months through +12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~-12 months through +12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and -12 months through +12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Patient no-shows

Secondary study objectives

Acute care use for avoidable conditions

Acute care use overall

Disability metric

+14 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Arm 3Experimental Treatment1 Intervention

Arm 3 will receive the assistance of a bilingual (English and Spanish) nurse patient navigator with nursing training and additional rheumatology-specific training.

Group II: Arm 2Experimental Treatment1 Intervention

Arm 2 will receive the assistance of a community resource specialist (CRS)- an individual without formal medical training with community-based expertise.

Group III: Arm 1Experimental Treatment1 Intervention

Arm 1 is the control arm which will receive the standard of care resource sheets.

Do I qualify?Apply below to find out